Fee Policy for COMIRB Review
| Submission | Fee |
| COMIRB Full Board Initial | $2,500 |
| COMIRB Full Board Continuing Review | $2,000 |
| COMIRB Expedited Initial | $950 |
| External IRB Initial (Industry-sponsored/initiated) | $5000 |
For more information about review by an external IRB (e.g., Advarra, WCG IRB, etc.), please see the Ceding Review to Another IRB page.
Full Fee Charged
COMIRB charges the full review fee for industry-sponsored research, as well as for research funded by awards administered by the affiliated institutions listed below.
- Denver Health and Hospital Authority (DHHA)
- VA Eastern Colorado Health Care System (ECHCS)
- Children's Hospital Colorado (CHCO)
- University of Colorado Health (UCHealth)
- Colorado Prevention Center (CPC)
No Fee Charged
COMIRB does not charge a review fee for federally funded research. If your study is not funded by industry or by an external award, COMIRB will not charge the review fee; researchers do not need to request a fee waiver in such cases.
Examples of studies that do not require a review fee include:
- Studies receiving National Institutes of Health (NIH) grants
- Subcontracted Federal agreements with entities such as:
- Adult AIDS Clinical Trials Group (AACTG)
- Bacteriology and Mycology Study Group (BAMSG)
- Center for Disease Control (CDC)
- Gynecological Oncology Group (GOG)
- Radiation Therapy Oncology Group (RTOG)
Fee Waiver or Reduction
Some studies that are subject to the review fees described above may qualify for a fee waiver or reduction. In order to apply for a waiver or reduction you will need to request a fee waiver via the billing form that appears at the end of the COMIRB application form.
Questions?
